Home/Filings/4/0001179110-17-010387
4//SEC Filing

New York & Company, Inc. 4

Accession 0001179110-17-010387

CIK 0001211351operating

Filed

Jul 13, 8:00 PM ET

Accepted

Jul 14, 5:21 PM ET

Size

13.3 KB

Accession

0001179110-17-010387

Insider Transaction Report

Form 4
Period: 2017-06-29
Ratner Adam
VP and General Counsel
Transactions
  • Award

    Stock Appreciation Rights

    2017-06-29+3,6253,625 total
    Exercise: $1.36Exp: 2024-08-19Common Stock (3,625 underlying)
  • Disposition to Issuer

    Stock Appreciation Rights

    2017-06-297,5000 total
    Exercise: $3.22Exp: 2024-08-19Common Stock (7,500 underlying)
  • Award

    Stock Appreciation Rights

    2017-06-29+4,0134,013 total
    Exercise: $1.36Exp: 2025-08-25Common Stock (4,013 underlying)
  • Disposition to Issuer

    Stock Appreciation Rights

    2017-06-296,5490 total
    Exercise: $2.60Exp: 2025-08-25Common Stock (6,549 underlying)
Footnotes (6)
  • [F1]Each Stock Appreciation Right (SAR) represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise the SARs will be settled in stock.
  • [F2]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program as more fully described in the Schedule TO, filed with the Securities and Exchange Commission on June 1, 2017. The reporting person was previously awarded SARs which were exercisable as follows: 1,875 on August 19, 2015, 1,875 on August 19, 2016, 1,875 on August 19, 2017, and 1,875 on August 19, 2018.
  • [F3]In exchange for each cancelled award pursuant to the Company's Stock Appreciation Right and Option Exchange Program, the reporting person received a replacement award for a lesser number of SARs with an equal fair value and an exercise price equal to the closing price of the Company's common stock as reported on the New York Stock Exchange on June 29, 2017.
  • [F4]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which vest as follows: 907 on August 19, 2017; 1,812 on June 29, 2018, and 906 on August 19, 2018.
  • [F5]Represents SARs cancelled pursuant to the Company's Stock Appreciation Right and Option Exchange Program. The reporting person was previously awarded SARs which were exercisable as follows: 1,637 on August 25, 2016, 1,637 on August 25, 2017, and 3,275 on August 25, 2018.
  • [F6]Represents Replacement SARs granted pursuant to the Company's Stock Appreciation Right and Option Exchange Program which vest as follows: 1,003 on August 25, 2017; 1,003 on June 29, 2018, and 2,007 on August 25, 2018.

Issuer

New York & Company, Inc.

CIK 0001211351

Entity typeoperating

Related Parties

1
  • filerCIK 0001211351

Filing Metadata

Form type
4
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 5:21 PM ET
Size
13.3 KB